Multibagger Healthcare Stock Zooms 18% In 1-Week, To Mull Interim Dividend, Special Dividend

Aster DM Healthcare, a leading player in the hospital business, on Monday surged in its share price, rallying by 10% on the Bombay Stock Exchange (BSE) to reach a record high of Rs 499.90.

This surge comes as the company announced its board's intention to convene on Friday, April 12, 2024, to deliberate on the declaration of an interim dividend and a special dividend.

The potential consideration of a special dividend follows the recent segregation of Aster DM Healthcare's GCC (Gulf Cooperation Council) business through the sale of its subsidiary, Affinity Holdings Pvt Ltd, to Alpha GCC Holdings Limited. This strategic move has generated excitement among investors, driving the surge in share prices.

Aster DM Healthcare has designated April 23, 2024, as the 'Record Date' for determining the entitlement of shareholders to the interim dividend for the financial year 2023-24, including the special dividend. This proactive measure underscores the company's commitment to transparency and shareholder value.

In the preceding four trading days, the stock has appreciated by a notable 22% following the completion of the separation of its India and GCC businesses on April 3. As part of this separation plan, a consortium of investors led by Fajr Capital, a sovereign-backed private equity firm, acquired a majority stake of 65% in Aster GCC. Meanwhile, the Moopen family, the founding family of Aster DM Healthcare, retained a 35% stake, reaffirming their continued involvement in the company's growth trajectory.

Regarding the financial implications of the transaction, Affinity Holdings Ltd., a wholly-owned subsidiary of Aster DM Healthcare, received a substantial cash consideration of $907.6 million. The company intends to distribute 70-80% of the transaction proceeds as dividends to its shareholders, with the potential range per share being Rs 110 to Rs 120. This announcement has further bolstered investor confidence and contributed to the positive momentum in the stock price.

Looking ahead, the management of Aster DM Healthcare remains optimistic about the prospects of the Indian healthcare market. Post-segregation, the company aims to strategically expand its footprint in India, leveraging both greenfield and brownfield opportunities.

Over the next three years, Aster DM Healthcare plans to increase its total bed capacity in India to over 6,600 beds, positioning itself as one of the top three integrated healthcare providers in the country. Additionally, the company aims to scale up its laboratory and pharmacy businesses to further solidify its position in the Indian healthcare landscape.

Aster DM Healthcare's recent surge in share price reflects investor confidence in the company's strategic initiatives and potential for value creation. With the prospect of a special dividend on the horizon and a focused expansion strategy in India, Aster DM Healthcare is poised for continued growth and success in the dynamic healthcare sector.